ATE513547T1 - Neue verfahren - Google Patents

Neue verfahren

Info

Publication number: ATE513547T1
Authority: AT; Austria
Prior art keywords: new procedures; procedures; new
Prior art date: 2007-02-21

Application number

AT08707469T

Other languages

English (en)

Inventor

Supervia Jorge Beleta

Original Assignee

Almirall Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-02-21

Filing date

2008-01-31

Publication date

2011-07-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39247776&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE513547(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-01-31 Application filed by Almirall Sa filed Critical Almirall Sa

2011-07-15 Application granted granted Critical

2011-07-15 Publication of ATE513547T1 publication Critical patent/ATE513547T1/de

Links

238000000034 method Methods 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pulmonology (AREA)
Neurology (AREA)
Epidemiology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Psychiatry (AREA)
Urology & Nephrology (AREA)
Ophthalmology & Optometry (AREA)
Otolaryngology (AREA)
Hospice & Palliative Care (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Psychology (AREA)
Nutrition Science (AREA)
Pain & Pain Management (AREA)
Vascular Medicine (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)

AT08707469T 2007-02-21 2008-01-31 Neue verfahren ATE513547T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US90284307P	2007-02-21	2007-02-21
PCT/EP2008/000782 WO2008101591A1 (en)	2007-02-21	2008-01-31	Novel methods

Publications (1)

Publication Number	Publication Date
ATE513547T1 true ATE513547T1 (de)	2011-07-15

Family

ID=39247776

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT08707469T ATE513547T1 (de)	2007-02-21	2008-01-31	Neue verfahren

Country Status (31)

Country	Link
US (2)	US20110243924A1 (de)
EP (1)	EP2120936B1 (de)
JP (2)	JP5739616B2 (de)
KR (2)	KR20090114401A (de)
CN (2)	CN101616670A (de)
AR (1)	AR065392A1 (de)
AT (1)	ATE513547T1 (de)
AU (1)	AU2008217301B2 (de)
BR (1)	BRPI0806392A8 (de)
CA (1)	CA2678975C (de)
CL (1)	CL2008000461A1 (de)
CO (1)	CO6210814A2 (de)
CY (1)	CY1111799T1 (de)
DK (1)	DK2120936T3 (de)
EC (1)	ECSP099556A (de)
ES (1)	ES2367722T3 (de)
HR (1)	HRP20110556T1 (de)
IL (1)	IL200278A (de)
MX (1)	MX2009008825A (de)
MY (1)	MY153408A (de)
NZ (1)	NZ578473A (de)
PE (1)	PE20081789A1 (de)
PL (1)	PL2120936T3 (de)
PT (1)	PT2120936E (de)
RU (1)	RU2484821C2 (de)
SI (1)	SI2120936T1 (de)
TW (1)	TWI475994B (de)
UA (1)	UA98136C2 (de)
UY (1)	UY30901A (de)
WO (1)	WO2008101591A1 (de)
ZA (1)	ZA200904941B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2165768B1 (es)	1999-07-14	2003-04-01	Almirall Prodesfarma Sa	Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
EP2100599A1 (de)	2008-03-13	2009-09-16	Laboratorios Almirall, S.A.	Inhalationszusammensetzung enthaltend Aclidinium zur Behandlung von Asthma sowie chronisch-obstruktiver Lungenerkrankung
EP2100598A1 (de)	2008-03-13	2009-09-16	Laboratorios Almirall, S.A.	Inhalationszusammensetzung enthaltend Aclidinium zur Behandlung von Asthma sowie chronisch-obstruktiver Lungenerkrankung
NZ597920A (en)	2009-08-07	2014-05-30	Generics Uk Ltd	Anhydrate of tiotropium bromide
WO2011095800A2 (en) *	2010-02-02	2011-08-11	Generics [Uk] Limited	Analytical methods
EP2510928A1 (de)	2011-04-15	2012-10-17	Almirall, S.A.	Aclidinium zur Verbesserung der Schlafqualität bei atemwegserkrankten Patienten
US10111957B2 (en)	2012-07-05	2018-10-30	Arven Ilac Snayi ve Ticaret A.S.	Inhalation compositions comprising glucose anhydrous
US10105316B2 (en)	2012-07-05	2018-10-23	Arven llac Sanayi Ve Ticaret A.S.	Inhalation compositions comprising muscarinic receptor antagonist
WO2014007767A1 (en) *	2012-07-05	2014-01-09	Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi	Dry powder inhalers comprising a carrier other than lactose and a ternary component
CA3071377C (en)	2017-01-09	2021-11-30	Kathleen E. Clarence-Smith	Compositions and methods for improving muscle weakness in patients suffering from myasthenia gravis and other myasthenic syndromes
TW201919704A (zh)	2017-07-25	2019-06-01	美商Ｇｔ生物製藥公司	利用吡啶斯的明（pyridostigmine）及nk-1拮抗劑治療重症肌無力之醫藥組合物及方法
WO2019023175A1 (en)	2017-07-25	2019-01-31	Gt Biopharma, Inc.	PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE AND NEOSTIGMINE AND AN ANTAGONIST NK-1 FOR THE TREATMENT OF SEVERE MYASTHENIA
WO2020014072A1 (en) *	2018-07-09	2020-01-16	Gt Biopharma, Inc.	Neostigmine pharmaceutical combination for treating myasthenia gravis
CN113825508A (zh) *	2020-05-20	2021-12-21	新泰克生物技术有限公司	用于预防或治疗严重急性呼吸综合征冠状病毒2感染疾病的组合物
KR102169476B1 (ko) *	2020-05-20	2020-10-23	(주)신테카바이오	제2형 중증급성호흡기증후군 코로나바이러스 감염 질환의 예방 또는 치료용 조성물
WO2023141721A1 (en) *	2022-01-28	2023-08-03	University Of Montréal	Anticholinergic compounds for use in treating neuromuscular disorders
CN115267024B (zh) *	2022-07-31	2023-06-30	浙江知一药业有限责任公司	治疗呼吸系统疾病的药物组合物及其检测方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2165768B1 (es) *	1999-07-14	2003-04-01	Almirall Prodesfarma Sa	Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
US20050026948A1 (en) *	2003-07-29	2005-02-03	Boehringer Ingelheim International Gmbh	Medicaments for inhalation comprising an anticholinergic and a betamimetic
DE102004016179A1 (de) *	2004-03-30	2005-10-20	Boehringer Ingelheim Pharma	Verbindungen zur Behandlung von proliferativen Prozessen
ES2257152B1 (es) *	2004-05-31	2007-07-01	Laboratorios Almirall S.A.	Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos.

2008
- 2008-01-31 UA UAA200909464A patent/UA98136C2/ru unknown
- 2008-01-31 KR KR1020097017243A patent/KR20090114401A/ko not_active Ceased
- 2008-01-31 MY MYPI20093444A patent/MY153408A/en unknown
- 2008-01-31 SI SI200830381T patent/SI2120936T1/sl unknown
- 2008-01-31 AT AT08707469T patent/ATE513547T1/de active
- 2008-01-31 HR HR20110556T patent/HRP20110556T1/hr unknown
- 2008-01-31 WO PCT/EP2008/000782 patent/WO2008101591A1/en not_active Ceased
- 2008-01-31 PL PL08707469T patent/PL2120936T3/pl unknown
- 2008-01-31 ES ES08707469T patent/ES2367722T3/es active Active
- 2008-01-31 CA CA2678975A patent/CA2678975C/en active Active
- 2008-01-31 EP EP08707469A patent/EP2120936B1/de active Active
- 2008-01-31 CN CN200880005871A patent/CN101616670A/zh active Pending
- 2008-01-31 KR KR20157007787A patent/KR20150038750A/ko not_active Ceased
- 2008-01-31 DK DK08707469.6T patent/DK2120936T3/da active
- 2008-01-31 AU AU2008217301A patent/AU2008217301B2/en active Active
- 2008-01-31 NZ NZ578473A patent/NZ578473A/en unknown
- 2008-01-31 US US12/528,267 patent/US20110243924A1/en not_active Abandoned
- 2008-01-31 MX MX2009008825A patent/MX2009008825A/es active IP Right Grant
- 2008-01-31 CN CN201510633145.XA patent/CN105395548A/zh active Pending
- 2008-01-31 PT PT08707469T patent/PT2120936E/pt unknown
- 2008-01-31 JP JP2009550665A patent/JP5739616B2/ja active Active
- 2008-01-31 BR BRPI0806392A patent/BRPI0806392A8/pt not_active Application Discontinuation
- 2008-01-31 RU RU2009135078/15A patent/RU2484821C2/ru active
- 2008-02-07 UY UY0001030901A patent/UY30901A/es unknown
- 2008-02-13 CL CL200800461A patent/CL2008000461A1/es unknown
- 2008-02-20 PE PE2008000361A patent/PE20081789A1/es not_active Application Discontinuation
- 2008-02-20 TW TW097105887A patent/TWI475994B/zh not_active IP Right Cessation
- 2008-02-20 AR ARP080100680A patent/AR065392A1/es unknown
2009
- 2009-07-15 ZA ZA2009/04941A patent/ZA200904941B/en unknown
- 2009-08-04 EC EC2009009556A patent/ECSP099556A/es unknown
- 2009-08-06 IL IL200278A patent/IL200278A/en active IP Right Grant
- 2009-08-21 CO CO09088171A patent/CO6210814A2/es not_active Application Discontinuation
2011
- 2011-08-31 CY CY20111100836T patent/CY1111799T1/el unknown
2013
- 2013-12-05 JP JP2013252283A patent/JP2014062114A/ja active Pending
2014
- 2014-12-05 US US14/561,857 patent/US20150093374A1/en not_active Abandoned

Also Published As

Publication number	Publication date
PE20081789A1 (es)	2008-12-27
AU2008217301A1 (en)	2008-08-28
IL200278A (en)	2015-03-31
HK1132673A1 (en)	2010-03-05
JP2010519261A (ja)	2010-06-03
ES2367722T3 (es)	2011-11-08
MX2009008825A (es)	2009-10-12
IL200278A0 (en)	2010-04-29
CL2008000461A1 (es)	2008-08-29
CN105395548A (zh)	2016-03-16
CN101616670A (zh)	2009-12-30
KR20090114401A (ko)	2009-11-03
EP2120936B1 (de)	2011-06-22
BRPI0806392A8 (pt)	2019-10-01
CO6210814A2 (es)	2010-10-20
RU2009135078A (ru)	2011-03-27
MY153408A (en)	2015-02-13
AR065392A1 (es)	2009-06-03
PL2120936T3 (pl)	2011-11-30
TW200838520A (en)	2008-10-01
AU2008217301B2 (en)	2012-10-04
TWI475994B (zh)	2015-03-11
CA2678975A1 (en)	2008-08-28
DK2120936T3 (da)	2011-09-26
PT2120936E (pt)	2011-09-06
UA98136C2 (ru)	2012-04-25
CY1111799T1 (el)	2015-10-07
UY30901A (es)	2009-11-10
HRP20110556T1 (hr)	2011-09-30
JP5739616B2 (ja)	2015-06-24
BRPI0806392A2 (pt)	2011-09-06
WO2008101591A1 (en)	2008-08-28
CA2678975C (en)	2016-11-08
US20110243924A1 (en)	2011-10-06
ECSP099556A (es)	2009-09-29
KR20150038750A (ko)	2015-04-08
JP2014062114A (ja)	2014-04-10
SI2120936T1 (sl)	2011-10-28
RU2484821C2 (ru)	2013-06-20
US20150093374A1 (en)	2015-04-02
ZA200904941B (en)	2011-11-30
NZ578473A (en)	2011-10-28
EP2120936A1 (de)	2009-11-25

Legal Events

Date

Code

Title

Description

2012-02-15

UEP

Publication of translation of european patent specification

Ref document number: 2120936

Country of ref document: EP

Publication	Publication Date	Title
ATE513547T1 (de)	2011-07-15	Neue verfahren
DE602007003343D1 (de)	2009-12-31	Neue mikrobiozide
ATE539628T1 (de)	2012-01-15	Filter
BRPI0814359A2 (pt)	2015-08-11	Método
BRPI0817226A2 (pt)	2015-06-16	Método
BRPI0817726A2 (pt)	2015-03-31	Método
NO347644B1 (no)	2024-02-12	Polymorfer
BRPI0915502A2 (pt)	2016-01-26	filtro
ATE554847T1 (de)	2012-05-15	Filter
DK2178568T3 (da)	2014-07-21	Kontrastmidler
EP2115162A4 (de)	2010-02-17	Adrb2-karzinommarker
BRPI0811008A2 (pt)	2015-01-27	Conjunto de filtro
AT505058A3 (de)	2008-12-15	Türschliesssystem
BRPI0809678A2 (pt)	2014-10-07	Métodos
EP2143714A4 (de)	2011-09-07	Tetrahydroisochinolinverbindung
BRPI0810416A2 (pt)	2014-10-14	Método de hidroformação
ATE506032T1 (de)	2011-05-15	Endoprothesenkomponente
ATE524461T1 (de)	2011-09-15	Neue substituierte piperidylpropanthiole
EP2214719A4 (de)	2014-10-01	Metallofulleren-kontrastmittel
BRPI0820217A2 (pt)	2015-06-16	Filtro
DE112007000480A5 (de)	2008-12-18	Filtervorrichtung
AT9563U3 (de)	2008-05-15	Wirbelsäulenzuggurtung
AT504425B8 (de)	2008-09-15	Portioniersteuerung
UA16217S (uk)	2008-04-10	Бланк для кореспонденції
FIU20060345U0 (fi)	2006-08-29	Pienoisgolf-rata